Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Vonoprazan or Proton-pump inhibitor for gastric endoscopic submucosal dissection in patients under antithrombotic therapy: a randomized prospective multicenter study

Next Previous
Trial Profile

Vonoprazan or Proton-pump inhibitor for gastric endoscopic submucosal dissection in patients under antithrombotic therapy: a randomized prospective multicenter study

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 07 Jun 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Vonoprazan (Primary) ; Esomeprazole
  • Indications Adenoma; Gastric cancer
  • Focus Therapeutic Use
  • Acronyms V-POINT

Most Recent Events

  • 03 Dec 2020 Status changed from not yet recruiting to recruiting.
  • 12 Sep 2020 Planned End Date changed from 31 Aug 2023 to 31 Mar 2024.
  • 12 Sep 2020 Planned initiation date changed from 1 Sep 2020 to 16 Sep 2020.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top